Syros Pharmaceuticals

Youtube Subscribe

Open: 4.34 Close: 4.16 Change: -0.18

Are you still looking for information about Syros Pharmaceuticals? An AI summarized it for you.

Are looking for the most relevant information about Syros Pharmaceuticals? Investor spend a lot of time searching for information to make investment decisions in Syros Pharmaceuticals. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Syros Pharmaceuticals are: Syros, Pharmaceuticals, Inc, SYRS, stock, SP, rise, and the most common words in the summary are: pharmaceutical, job, stock, best, syros, report, news, . One of the sentences in the summary was: Syros is laying off 35% of its workforce, and its CEO …

Concept Map

Semantic Network

Stock Summary

Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibar.

Today's Summary

Syros Pharmaceuticals Inc (SYRS) stock is down -7.74% while the S&P 500 has risen 0.57% as of 2:01 PM on Wednesday, Dec 13. Syros is laying off 35% of its workforce, and its CEO and chief science officer are also departing. Syros Pharmaceuticals announces encouraging initial data from randomized SELECT-AML-1 Phase 2 clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine.

Today's News

Syros Pharmaceuticals Inc (SYRS) stock is down -7.74% while the S&P 500 has risen 0.57% as of 2:01 PM on Wednesday, Dec 13. Syros is laying off 35% of its workforce, and its CEO and chief science officer are also departing. Syros Pharmaceuticals announces encouraging initial data from randomized SELECT-AML-1 Phase 2 clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine.

Stock Profile

" Syros Pharmaceuticals shares fall 18% on staff cuts, ceo retirement - MarketWatch. CEO leaves a deep and lasting impact on our company and the patients globally who we hope to treat Shares fell after the company cut more than one- third of its staff. Syros Pharmaceuticals to cut 35% of staff; CEO Simonian to retire - MarketWatch. Pfizer terminating license agreement with Syros for sickle cell disease and beta-thalassemia. Company tightens focus on key drug candidate tamibarotene."

Keywords

How much time have you spent trying to decide whether investing in Syros Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Syros Pharmaceuticals are: Syros, Pharmaceuticals, Inc, SYRS, stock, SP, rise, and the most common words in the summary are: pharmaceutical, job, stock, best, syros, report, news, . One of the sentences in the summary was: Syros is laying off 35% of its workforce, and its CEO and chief science officer are also departing. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #job #stock #best #syros #report #news.

Read more →

Youtube Subscribe

---